Every year, our scientists and patient advisory group identify the studies and topics creating the most impact for people living with arthritis.
Uncover Our Focus for 2026Ongoing and completed studies across our full research portfolio, from prevention and treatment to care and health systems.
Explore Our ResearchMeet the scientists, clinicians, trainees, and patient advisory board members, driving discoveries
Meet Our TeamPeople living with arthritis guide our research priorities, shape study design, and ensure our work reflects real life.
Support Arthritis Research Canada with your time and skills. Whether you want to help at an event or host your own, there is a place for you here.
Living with arthritis? Explore open studies looking for participants and help shape the future of arthritis care.
Your experience with arthritis matters. Sharing it helps others feel less alone and brings the human reality of arthritis into everything we do.
Reason For Research
In December 2019, SARS-COV-2 was identified as a new respiratory illness and eventually declared a global pandemic (COVID-19). To slow the spread of COVID-19, public health measures such as physical distancing and changes to the delivery of health care (e.g., virtual appointments, delayed surgery/treatment) were established.
Individuals with rheumatic diseases are particularly vulnerable to COVID-19, as they are at greater risk of other health issues and infections. To optimize healthcare delivery and provide better support to patients during the COVID-19 pandemic, we aimed to understand the impacts of COVID-19 on the care, treatment, and mental health of individuals living with rheumatic diseases. Specifically, we wanted to understand how patients felt about virtual health appointments during the pandemic and examine how loneliness and social isolation relate to depression and anxiety.
Execution of Research
This study was conducted in two parts, both using international online surveys (available in English and French) to collect information from adults (age 18+) with rheumatic diseases. We recruited participants through social media, supported by patient partners and Arthritis Research Canada.
Part 1 included a survey that was open between April – June 2020 and asked about demographics, disease types, treatments, and experiences with virtual rheumatology care.
Part 2 included two surveys:
We asked about:
Survey Part 1
Sample size 429 Average Age 41 years % identified as female 91% North American participants 73% Disease type: Rheumatoid Arthritis 58% Early pandemic: Reported change in treatment 26% Early pandemic: stopped a prescribed medication 14% Attended virtual rheumatology appointment 44% Felt supported by rheumatology care providers 59% Satisfied with virtual health care appointments 71% Preference for in-person appointments when receiving difficult news 65%
Survey Part 2
Initial participation 718 Average Age 45 years % identified as female 91% Follow-up participation 344 Feeling lonely 51% Feeling socially isolated 30% Depression 43% Anxiety 34%
Experiencing both loneliness and social isolation was linked to significantly higher depression and anxiety scores.
What Does This Mean?
This study revealed that the COVID-19 pandemic led to changes in the delivery of rheumatology care, with many healthcare providers offering virtual appointments. Based on our findings, we recommend that rheumatologists prioritize in-person appointments when discussing difficult news, ensure patient preferences are considered, and be mindful of resources.
This study also revealed that many people with rheumatic diseases experienced loneliness and social isolation during the COVID-19 pandemic, which was strongly associated with higher levels of depression and anxiety. Although COVID-19 restrictions are easing, it is important to remember that people with rheumatic diseases, who may have weakened immune systems, are still affected by the pandemic and may continue to suffer from loneliness and social isolation.